A Case of Recurrent Cervical Cancer Treated with Cadonilimab Monotherapy and Combination Chemotherapy

doi:10.12280/gjfckx.20230672

Abstract

Abstract:

The incidence rate of cervical cancer is the highest among gynecological malignancies. At present, surgery is still an effective treatment for early-stage cervical cancer, but cervical cancer has a high recurrence rate and distant metastasis, poor prognosis in advanced stages, and limited treatment options. This article focuses on a case with recurrence of cervical cancer despite radical hysterectomy and combined chemotherapy and radiotherapy, who developed vesicovaginal fistula and rectovaginal fistula with severe infection, and achieved a survival benefit by treatment with cadonilimab monotherapy and combination chemotherapy. It aims to provide new ideas for the treatment of recurrent cervical cancer.

Key words: Uterine cervical neoplasms, Immunotherapy, Cadonilimab, Recurrence, Drug therapy, Drug therapy, combination

SHI Rui, FENG Shu-xian, MA Wei, ZHANG Zong-cui. A Case of Recurrent Cervical Cancer Treated with Cadonilimab Monotherapy and Combination Chemotherapy[J]. Journal of International Obstetrics and Gynecology, 2023, 50(6): 665-667.

Figures/Tables 3

References 8

[1]	Ji J, Lin S, Li Z, et al. A phase Ⅰb/Ⅱ, multicenter, open-label study of AK104, a PD-1/CTLA-4 bispecific antibody, combined with chemotherapy (chemo) as first-line therapy for advanced gastric (G) or gastroesophageal junction (GEJ) cancer: 2-Year update data[J]. J Clin Oncol, 2023, 41(16_suppl):4031. doi: 10.1200/JCO.2023.41.16_suppl.4031.
[2]	Bai L, Sun M, Xu A, et al. Phase 2 study of AK104 (PD-1/CTLA-4 bispecific antibody) plus lenvatinib as first-line treatment of unresectable hepatocellular carcinoma[J]. J Clin Oncol, 2021, 39(15_suppl):4101. doi: 10.1200/JCO.2021.39.15_suppl.4101.
[3]	Liontos M, Kyriazoglou A, Dimitriadis I, et al. Systemic therapy in cervical cancer: 30 years in review[J]. Crit Rev Oncol Hematol, 2019, 137:9-17. doi: 10.1016/j.critrevonc.2019.02.009. pmid: 31014518
[4]	Attademo L, Tuninetti V, Pisano C, et al. Immunotherapy in cervix cancer[J]. Cancer Treat Rev, 2020, 90:102088. doi: 10.1016/j.ctrv.2020.102088.
[5]	张宋安, 张洋, 古丽仙·吐鲁翁江, 等. PD-L1与PD-1在宫颈鳞癌与宫颈良性病变组织及外周血中的表达及其预后价值[J]. 现代肿瘤医学, 2018, 26(8):1246-1251. doi: 10.3969/j.issn.1672-4992.2018.08.025.
[6]	张敬茹, 赵立波, 顾健. 非小细胞肺癌一线治疗新药PD-1抑制剂pembrolizumab[J]. 中国新药杂志, 2018, 27(9):969-972.
[7]	Chung HC, Ros W, Delord JP, et al. Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase Ⅱ KEYNOTE-158 Study[J]. J Clin Oncol, 2019, 37(17):1470-1478. doi: 10.1200/JCO.18.01265.
[8]	Wu X, Ji J, Lou H, et al. Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase Ⅱ trial (075)[J]. Gynecol Oncol, 2022, 166:S47-S48. doi: 10.1016/S0090-8258(22)01293-8.

[1]	GUO Jing, ZHANG Mao-xiang, ZHOU Chun-he, LIU Si-ning, LI Hui-yan. The Progress of Mendelian Randomization in the Study of the Causal Relationship between Exposure Factors and Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 169-174.
[2]	CHAI Ling-na, LI Yan-li, SHI Jie, GAO Han, OUYANG Xi-yan, CHENG Shi-yu. Clinical Application of Indocyanine Green Tracing of Sentinel Lymph Nodes in Early Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 175-179.
[3]	CHEN Xiu-jie, WANG Ya-nan, CHENG Qian-qian, ZHANG Ji-wen, SONG Dian-rong. Lesion Resection Combined with Skin Flap Transplantation in the Treatment of Recurrent Vulvar Paget′s Disease: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 237-240.
[4]	BAI Yao-jun, WANG Si-yao, LING Fei-fei, ZHANG Sen-huai, LI Hong-li, LIU Chang. Progress of Trop-2 and Targeted Trop-2 Antibody-Coupled Drugs in Gynecological Malignant Tumors [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 1-7.
[5]	HU Ming-zhu, LIU Li-wen, HUANG Lei. The Relationship between Vaginal Microecology and Cervical Cancer in HIV-Infected Women [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 13-18.
[6]	JIA Yan-feng, WU Zhen-zhen, WANG Wei-hong, WANG Yue-yuan, LI Juan. A Case of Primary Ovarian Adenosquamous Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 32-36.
[7]	LUO Na, CHEN Yan. A Case of Recurrent Uterine Smooth Muscle Tumor of Uncertain Malignant Potential Underwent Hysterectomy after Hysteroscopic Lesion Resection [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 42-45.
[8]	ZHANG Ye, CHEN Qiao-yun, ZHAO Jia-yi, CHEN Lu, LIU Jian-rong. Progress in the Application of Nanoparticles in the Prevention and Treatment of Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 8-12.
[9]	LI Dan-ning, WANG Xi-peng. Research Progress on Utilizing Single-Cell Sequencing Technology to Investigate Tumor Immune Microenvironment in Epithelial Ovarian Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 654-658.
[10]	WEI Jin-hua, QI Yu-chao, SHEN Xiao-ya. Analysis on the Incidence and Mortality of Cervical Cancer in China Based on the Age-Period-Cohort Model from 1992 to 2021 [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 664-668.
[11]	LIU Yu, WU Rui-fang, LI Rui-zhen. A Case Report of Pregnancy after Radical Cervicectomy with Neoadjuvant Chemotherapy in Stage ⅠB2 Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 669-671.
[12]	SONG Han, LIU Han-li, WANG Xi-bo. A Case of Soft Tissue Metastasis in the Back from Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 672-675.
[13]	BAI Yao-jun, HU Xiao-hong, LI Hong-li, LIU Chang. Research Progress on Lymphocyte Activation Gene-3 in Gynecological Tumors [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 566-571.
[14]	MING Yang, HU Yuan-yuan, FENG Tong-fu. A Case of Recurrent Cellular Uterine Leiomyoma with Peritoneal Dissemination after Surgery [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 593-596.
[15]	WANG Jing, WANG Xiao-hui. Cervical Carcinosarcoma：A Case Report and Literature Review [J]. Journal of International Obstetrics and Gynecology, 2024, 51(5): 597-600.